Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?

BACKGROUND. Borderline resectable pancreatic cancer is best treated by multimodality therapy. FOLFIRINOX (5-fluorouracil, oxaliplatin, irinotecan, and leucovorin) tripled the response rate and significantly increased median survival for patients with advanced pancreatic cancer and shows promise for...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Christians, Kathleen K., Tsai, Susan, Mahmoud, Anna, Ritch, Paul, Thomas, James P., Wiebe, Lauren, Kelly, Tracy, Erickson, Beth, Wang, Huamin, Evans, Douglas B., George, Ben
格式: Artigo
語言:Inglês
出版: AlphaMed Press 2014
主題:
Gastrointestinal Cancer
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3958454/
https://ncbi.nlm.nih.gov/pubmed/24569947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0273
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍